Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Invested Capital: 2022-2024

  • Autolus Therapeutics' Return on Invested Capital was N/A to -0.35% in Q2 2024 from the same period last year, while for Jun 2024 it was -0.35%, marking a year-over-year change of. This contributed to the annual value of -0.88% for FY2023, which is N/A change from last year.
  • Latest data reveals that Autolus Therapeutics reported Return on Invested Capital of -0.35% as of Q2 2024, which was up 32.44% from -0.52% recorded in Q1 2024.
  • In the past 5 years, Autolus Therapeutics' Return on Invested Capital ranged from a high of -0.35% in Q2 2024 and a low of -1.23% during Q4 2023.
  • In the last 3 years, Autolus Therapeutics' Return on Invested Capital had a median value of -0.58% in 2022 and averaged -0.68%.